You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Showing 2501 - 2525 of 3,563
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation Trial in Worldwide (Dispersion ablation + PVI, VX1, PVI)

Recruiting
  • Atrial Fibrillation
  • Dispersion ablation + PVI
  • +2 more
  • Birmingham, Alabama
  • +25 more
May 12, 2022

Human Epilepsy Project 3

Recruiting
  • Idiopathic Generalized Epilepsy
    • San Francisco, California
    • +17 more
    May 11, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in United States (FT-7051)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Scottsdale, Arizona
    • +7 more
    May 12, 2022

    Abdominal Aortic Aneurysm Trial in United States (TREO Abdominal Stent-Graft System)

    Recruiting
    • Abdominal Aortic Aneurysm
    • TREO Abdominal Stent-Graft System
    • Phoenix, Arizona
    • +39 more
    May 13, 2022

    Clostridioides Difficile Infection Trial in United States (Ridinilazole, Vancomycin)

    Recruiting
    • Clostridioides Difficile Infection
    • Los Angeles, California
    • +17 more
    May 12, 2022

    Breast Cancer Invasive, Prostate Cancer Trial in New York (Audiovisual Intervention- Radiation Therapy Education, ASTRO

    Recruiting
    • Breast Cancer Invasive
    • Prostate Cancer
    • Audiovisual Intervention- Radiation Therapy Education
    • +3 more
    • New York, New York
      Columbia University Irving Medical Center
    May 10, 2022

    Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB

    Recruiting
    • Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
    • +2 more
    • Intensity-Modulated Radiation Therapy
    • +4 more
    • Birmingham, Alabama
    • +21 more
    May 13, 2022

    Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc Trial in Canada, United States (Brentuximab Vedotin, Placebo)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • +2 more
    • Brentuximab Vedotin
    • Placebo
    • Los Angeles, California
    • +9 more
    May 12, 2022

    Gastric Bypass, Weight Regain Trial in Boston, New York (Napoleon, Visual estimation)

    Recruiting
    • Gastric Bypass
    • Weight Regain
    • Napoleon
    • Visual estimation
    • Boston, Massachusetts
    • +1 more
    May 9, 2022

    Pancreas Cancer, Gastrointestinal Adenocarcinoma Trial in New York (ultrasound)

    Recruiting
    • Pancreas Cancer
    • Gastrointestinal Adenocarcinoma
    • ultrasound
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 12, 2022

    Prostate Cancer, Erectile Dysfunction Trial in New York (questionnaires, three in-person sessions, monthly phone calls)

    Recruiting
    • Prostate Cancer
    • Erectile Dysfunction
    • questionnaires
    • +4 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 11, 2022

    Superficial Bladder Cancer Trial in United States (EG-70)

    Recruiting
    • Superficial Bladder Cancer
    • Tucson, Arizona
    • +7 more
    May 11, 2022

    Immune Thrombocytopenia, Immune Thrombocytopenic Purpura Trial in Worldwide (PRN1008)

    Recruiting
    • Immune Thrombocytopenia
    • Immune Thrombocytopenic Purpura
    • Peoria, Illinois
    • +29 more
    May 11, 2022

    Snapshot Camera for AMD

    Not yet recruiting
    • Age Related Macular Degeneration
    • adaptive optics AO-OCT/AF instrument
    • New York, New York
      New York Eye and Ear Infirmary of Mount Sinai
    May 11, 2022

    Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer Trial in Australia, Canada, United States (IDE196, Binimetinib,

    Recruiting
    • Metastatic Uveal Melanoma
    • +3 more
    • Scottsdale, Arizona
    • +13 more
    May 10, 2022

    Colonic Polyp Trial in Brooklyn, New York (Visual estimation of polyp size, Napoleon measurement of polyp size)

    Recruiting
    • Colonic Polyp
    • Visual estimation of polyp size
    • Napoleon measurement of polyp size
    • Brooklyn, New York
    • +3 more
    May 6, 2022

    Wrinkle Trial in United States (GAL1906)

    Recruiting
    • Wrinkle
    • GAL1906
    • Birmingham, Alabama
    • +13 more
    May 9, 2022

    Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral

    Recruiting
    • Glioblastoma
    • +6 more
    • Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
    • Temozolomide and Radiation Alone
    • New York, New York
      Lenox Hill Brain Tumor Center
    May 5, 2022

    Pain, Postoperative, Opioid Use, Knee Osteoarthritis Trial in New York (cannabidiol, Ora-sweet SF)

    Recruiting
    • Pain, Postoperative
    • +2 more
    • New York, New York
      Hospital for Special Surgery
    May 5, 2022

    Opioid-use Disorder, Substance Use Disorders Trial in Blauvelt, Jamaica, New York (Metrics-driven quality improvement (MDQI))

    Recruiting
    • Opioid-use Disorder
    • Substance Use Disorders
    • Metrics-driven quality improvement (MDQI)
    • Blauvelt, New York
    • +3 more
    May 6, 2022

    Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

    Recruiting
    • Carcinoma, Renal Cell
    • New York, New York
      Columbia University Medical Center
    May 6, 2022

    PTSD Trial in New York (Transcranial magnetic stimulation (TMS))

    Recruiting
    • PTSD
    • Transcranial magnetic stimulation (TMS)
    • New York, New York
      NYU Langone Health
    May 5, 2022

    Accelerated/Blast-phase Myeloproliferative Tumor, Chronic-phase Myelofibrosis, IDH2 Mutation Trial in Canada, United States

    Recruiting
    • Accelerated/Blast-phase Myeloproliferative Neoplasm
    • +2 more
    • Scottsdale, Arizona
    • +10 more
    May 9, 2022

    Papulopustular Rosacea Trial in United States (DFD-29, Doxycycline, Placebo)

    Recruiting
    • Papulopustular Rosacea
    • Rogers, Arkansas
    • +26 more
    May 8, 2022

    Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)

    Recruiting
    • Recurrent World Health Organization (WHO) Grade II Glioma
    • Birmingham, Alabama
    • +11 more
    May 6, 2022